The Gene Lay Institute of Immunology and Inflammation announced on October 27, 2026, that it had appointed four scientists to its research leadership, including two core faculty members and two institute members.

Key Takeaways

  • Marco Colonna and Francisco J. Quintana were named core faculty members.
  • Howard L. Weiner and Jun R. Huh joined as institute members.

Gene Lay Institute names core faculty

Colonna joins from Washington University in St. Louis, with joint affiliations at Massachusetts General Hospital, Harvard Medical School and the Broad Institute. His work includes innate immunity, microglial biology and interactions between the nervous and immune systems.

Quintana, an investigator at the institute since its inception, will serve as a core faculty member and leader of its Program on Aging and Immunity. He studies how metabolism, environmental factors and the gut microbiome affect neuroinflammation.

Institute members bring neuroimmunology expertise

Weiner is director of the Brigham Multiple Sclerosis Center and co-director of the Ann Romney Center for Neurologic Diseases. His work includes clinical trials of nasal anti-CD3 monoclonal antibody therapies for several neurological conditions.

Huh, an associate professor of immunology at Harvard Medical School, studies how immune cytokines and substances produced by gut bacteria affect neural circuits and gut inflammation.

The institute was founded in 2023 with a gift from biotech entrepreneur Gene Lay. It brings together researchers from Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School to study interactions between the immune system and other organs.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.